Literature DB >> 23229164

Churg-Strauss syndrome presenting with acute kidney injury in a case of primary focal segmental glomerulosclerosis.

Sachin B Patil1, Aruna V Vanikar, Manoj R Gumber, Vivek B Kute, Pankaj R Shah, Himanshu V Patel, Hargovind L Trivedi.   

Abstract

Churg-Strauss syndrome (CSS) also called allergic granulomatosis and angiitis is a multisystem disorder. Churg-Strauss syndrome is defined as an eosinophil-rich, granulomatous inflammation involving the respiratory tract, along with necrotizing vasculitis affecting small- to medium-sized vessels, and is associated with asthma and eosinophilia. Renal involvement in CSS varies from 26 to 88 % but is usually of mild to moderate stage, and advanced renal failure is uncommon. We encountered an unusual case of 27-year-old man with asthma and primary focal segmental glomerulosclerosis diagnosed as CSS showing myeloperoxidase anti-neutrophil cytoplasmic antibody-associated acute kidney injury with crescentic glomerulonephritis. Patient responded to steroid and cyclophosphamide. Over a follow-up of 2 months, he has no hematuria/eosinophilia and serum creatinine of 2.3 mg/dL has decreased to 1.7 mg/dL.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23229164     DOI: 10.1007/s11255-012-0333-7

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  13 in total

1.  Renal involvement in Churg-Strauss syndrome.

Authors:  Renato Alberto Sinico; Lucafrancesco Di Toma; Umberto Maggiore; Cinzia Tosoni; Paolo Bottero; Ettore Sabadini; Gaia Giammarresi; Bruno Tumiati; Gina Gregorini; Alberto Pesci; Stefano Monti; Genesio Balestrieri; Giovanni Garini; Filomena Vecchio; Carlo Buzio
Journal:  Am J Kidney Dis       Date:  2006-05       Impact factor: 8.860

2.  Churg-Strauss syndrome with poor-prognosis factors: A prospective multicenter trial comparing glucocorticoids and six or twelve cyclophosphamide pulses in forty-eight patients.

Authors:  Pascal Cohen; Christian Pagnoux; Alfred Mahr; Jean-Pierre Arène; Luc Mouthon; Véronique Le Guern; Marie-Hélène André; Martine Gayraud; David Jayne; Daniel Blöckmans; Jean-François Cordier; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2007-05-15

3.  Allergic granulomatosis, allergic angiitis, and periarteritis nodosa.

Authors:  J CHURG; L STRAUSS
Journal:  Am J Pathol       Date:  1951 Mar-Apr       Impact factor: 4.307

Review 4.  The effects of glucocorticoids on human eosinophils.

Authors:  R P Schleimer; B S Bochner
Journal:  J Allergy Clin Immunol       Date:  1994-12       Impact factor: 10.793

5.  The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis).

Authors:  A T Masi; G G Hunder; J T Lie; B A Michel; D A Bloch; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt
Journal:  Arthritis Rheum       Date:  1990-08

6.  Eosinophilic myocarditis in a patient with idiopathic hypereosinophilic syndrome: insights into mechanisms of myocardial cell death.

Authors:  Domenico Corradi; Augusto Vaglio; Roberta Maestri; Vivian Legname; Giuseppe Leonardi; Giovanni Bartoloni; Carlo Buzio
Journal:  Hum Pathol       Date:  2004-09       Impact factor: 3.466

Review 7.  Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome.

Authors:  J G Lanham; K B Elkon; C D Pusey; G R Hughes
Journal:  Medicine (Baltimore)       Date:  1984-03       Impact factor: 1.889

Review 8.  Vasculitides with predominantly renal involvement: influence of age on the mode of presentation.

Authors:  A Serra; R Romero
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

9.  Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients.

Authors:  L Guillevin; F Lhote; M Gayraud; P Cohen; B Jarrousse; O Lortholary; N Thibult; P Casassus
Journal:  Medicine (Baltimore)       Date:  1996-01       Impact factor: 1.889

10.  Treatment of Churg-Strauss syndrome without poor-prognosis factors: a multicenter, prospective, randomized, open-label study of seventy-two patients.

Authors:  Camillo Ribi; Pascal Cohen; Christian Pagnoux; Alfred Mahr; Jean-Pierre Arène; Dominique Lauque; Xavier Puéchal; Philippe Letellier; Philippe Delaval; Jean-François Cordier; Loïc Guillevin
Journal:  Arthritis Rheum       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.